All News #Library
Others
Peptron`s PT105 established the bioequivalence with Takeda`s Leuplin
28 Nov 2022 //
PRNEWSWIRE
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
16 Apr 2021 //
PRNEWSWIRE
Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide
23 Apr 2018 //
PR NEWSWIRE

Market Place
Sourcing Support